BioPharma

21 October, 2026 | Wednesday | News

PharmaEssentia Accelerates Global Expansion with US and Japan Drug Approvals and US$46 Million Manufacturing Investment

PharmaEssentia Corporation (TWSE: 6446), a Taiwan-based biopharmaceutical company, is expanding its global presence through new drug approvals, clinical trials and overseas investments, as it seeks to bri...

Lab

20 October, 2026 | Tuesday | News

Cotecna Accelerates India Life Sciences Expansion With Acquisition of Hyderabad-Based Energon Labs

Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services,  announced the acquisition of Energon Labs, a cGMP-compliant, USFDA-inspected, ISO 9001:2015 and ISO 17025:2017 certifie...

BioTech

22 October, 2026 | Thursday | News

Metabolon Launches AI-Enabled Splash & Ripple to Accelerate Metabolomics-Driven Drug Discovery

New bioinformatics application combines curated metabolite-protein knowledge, advanced network algorithms, interactive exploration, and optional AI interpretation to generate clearer mechanistic hypotheses Met...

Contract Services

23 October, 2026 | Friday | News

ESTEVE CDMO Invests Over $80 Million to Expand Pharmaceutical Manufacturing Capabilities in China

After more than two decades in China, ESTEVE CDMO marks a new chapter in its commitment to the country and the region. With more than $80 million invested, the new facility brings a new gene...

Consumer Health

26 October, 2026 | Monday | News

Tairex Unveils AI-Powered Agent Hospital Ecosystem to Transform Multidisciplinary Clinical Decision-Making

Tairex, an AI healthcare technology company incubated by the Institute for AI Industry Research (AIR) at Tsinghua University, unveiled the Multidisciplinary Human-Agent Collaboration (MHAC) Ecosystem for Agent ...

Medtech

26 October, 2026 | Monday | News

Lunit and Summit Therapeutics Join Forces to Decode Tumour Biology with AI-Powered Pathology

Research Will Use Lunit's AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology Lunit Inc. (KRX: 328130) and Summit Therapeutics...

Cell & Gene

23 October, 2026 | Friday | News

Therakos Secures EU MDR Approval for First-of-Its-Kind Therapy to Manage Cancer Immunotherapy Toxicities

Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal photopheresis (ECP), announced that its THERAKOS™ CELLEX™ Photopheresis Sys...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close